<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1263894</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Insights in adrenal endocrinology: 2023</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Maciejczyk</surname>
<given-names>Mateusz</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/370125"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gilis-Januszewska</surname>
<given-names>Aleksandra</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1088112"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Hygiene, Epidemiology, and Ergonomics, Medical University of Bialystok</institution>, <addr-line>Bialystok</addr-line>, <country>Poland</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Chair and Department of Endocrinology, Jagiellonian University Medical College</institution>, <addr-line>Krakow</addr-line>, <country>Poland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Henrik Falhammar, Karolinska Institutet (KI), Sweden</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Mateusz Maciejczyk, <email xlink:href="mailto:mat.maciejczyk@gmail.com">mat.maciejczyk@gmail.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1263894</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Maciejczyk and Gilis-Januszewska</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Maciejczyk and Gilis-Januszewska</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/48522" ext-link-type="uri">Editorial on the Research Topic <article-title>Insights in adrenal endocrinology: 2023</article-title>
</related-article>
<kwd-group>
<kwd>adrenal endocrinology</kwd>
<kwd>latest insights</kwd>
<kwd>periodontitis (inflammatory)</kwd>
<kwd>cortisol</kwd>
<kwd>cystic fibrosis</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="8"/>
<page-count count="2"/>
<word-count count="565"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Adrenal Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Recent years are leading to significant advances in the rapidly developing field of adrenal endocrinology (<xref ref-type="bibr" rid="B1">1</xref>). The Research Topic, <italic>Insights in adrenal endocrinology: 2023</italic>, was to shed light on the advances made over the past decade in the field of adrenal endocrinology and the challenges ahead to provide a thorough overview of the field.</p>
<p>Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders caused by impairment at one of the steps of cortisol biosynthesis in the adrenal cortex (<xref ref-type="bibr" rid="B2">2</xref>). CAH caused by 3&#x3b2;-HSD deficiency is a rare form of congenital adrenal deficiency with an autosomal recessive type of inheritance, with an estimated overall incidence of less than 1/1 000 000 (<xref ref-type="bibr" rid="B3">3</xref>). However, the prevalence may be substantially higher in inbred populations. In this regard, in this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2023.1146768">Makretskaya et&#xa0;al.</ext-link> in a study based on genotyping of the NM_000198.3:c.690G&gt;A (p.W230X) variant performed by Real-time PCR in 339 healthy individuals of Ossetian origin have demonstrated a high frequency of p.W230X variant, most likely attributed to a founder effect.</p>
<p>Periodontitis is a multifactorial disease that destroys periodontal tissue. Current research suggests a positive association between stress and periodontitis. In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2023.1147739">Lee et&#xa0;al.</ext-link> investigated the neuroendocrine responses according to the presence or absence of psychological stress in patients with gingivitis and periodontitis compared to the control group. They showed significant differences in stress-related neuroendocrine biomarkers according to the severity of periodontal disease. Multivariate logistic regression showed that above-average cortisol levels and the cortisol/dehydroepiandrosterone (DHEA) ratio were significant predictors of psychological stress in patients with gingivitis and periodontitis. The association of cortisol with periodontitis was also assessed by  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2023.1100985">Baumeister et&#xa0;al</ext-link>.  In their cohort study, serum cortisol levels were analyzed with periodontal outcomes. The effect of genetically proxied morning plasma cortisol levels on periodontitis was also examined. It was found that cortisol levels were positively associated with clinical attachment level (CAL), deep interdental CAL, and bleeding on probing but were not associated with mean pocket depth and deep periodontal pockets, revealing the association of point cortisol levels with periodontitis indicators. In contrast to the observational study, genetically instrumented long-term cortisol was not associated with periodontitis.</p>
<p>Cystic fibrosis (CF) is an inherited syndrome associated with a mutation in a cystic fibrosis transmembrane conductance regulator gene, composed of exocrine gland dysfunction involving multiple systems that may result in chronic respiratory infections, pancreatic enzyme deficiency, and developmental disorders (<xref ref-type="bibr" rid="B4">4</xref>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2022.1074209">Podg&#xf3;rski et&#xa0;al.</ext-link> described the urinary profile of glucocorticoid metabolites and the activity of the enzymes involved in the development and metabolism of cortisol in patients with CF using a gas chromatography/mass spectrometry method. A general decrease in the activity of enzymes involved in the peripheral metabolism of cortisol in the liver and other tissues, such as 11&#x3b2;HSD2, SRD5A, and SRD5B was shown, while the activity of 11&#x3b2;HSD1-enzyme was increased. A significant decrease in glucocorticoid excretion in CF patients has been found, suggesting limitations in adrenocortical secretion or dysregulation of the hypothalamic&#x2013;pituitary&#x2013;adrenal (HPA) axis.</p>
<p>To conclude, the purpose of this Research Topic was to compile some new insights on adrenal endocrinology, bringing together a compendium of etiologies and diagnoses based on the excellent contributions of the expert authors in the area.</p>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>MM: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. AG-J Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. </p>
</sec>
</body>
<back>
<sec id="s2" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falhammar</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Specialty grand challenge in adrenal endocrinology</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2023</year>) <volume>14</volume>:<elocation-id>1237733</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2023.1237733</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claahsen-van der Grinten</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Speiser</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Arlt</surname> <given-names>W</given-names>
</name>
<name>
<surname>Auchus</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Falhammar</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management</article-title>. <source>Endocr Rev</source> (<year>2022</year>) <volume>43</volume>:<fpage>91</fpage>&#x2013;<lpage>159</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endrev/bnab016</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allis</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>A broken pathway: understanding congenital adrenal hyperplasia in the newborn</article-title>. <source>Neonatal Netw</source> (<year>2021</year>) <volume>40</volume>:<page-range>286&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1891/11-T-694</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makretskaya</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kalinchenko</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tebieva</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ionova</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zinchenko</surname> <given-names>R</given-names>
</name>
<name>
<surname>Marakhonov</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians</article-title>.
<source>Front Endocrinol (Lausanne)</source> (<year>2023</year>) <volume>14</volume> doi:<pub-id pub-id-type="doi">10.3389/fendo.2023.1146768</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Suk</surname> <given-names>C</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>S-I</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>J-Y</given-names>
</name>
</person-group>. <article-title>Salivary cortisol, dehydroepiandrosterone, and chromogranin A levels in patients with gingivitis and periodontitis and a novel biomarker for psychological stress</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2023</year>) <volume>14</volume> doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2023.1147739</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baumeister</surname> <given-names>S-E</given-names>
</name>
<name>
<surname>Reckelkamm</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Grabe</surname> <given-names>H-J</given-names>
</name>
<name>
<surname>Nauck</surname> <given-names>M</given-names>
</name>
<name>
<surname>Klinger-K&#xf6;nig</surname> <given-names>J</given-names>
</name>
<name>
<surname>V&#xf6;lzke</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Cortisol and periodontitis: Prospective observational and Mendelian randomization studies</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2023</year>) <volume>14</volume> doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2023.1100985</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tekerlek</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yard&#x131;mc&#x131;-Lokmano&#x11f;lu</surname> <given-names>BN</given-names>
</name>
<name>
<surname>Inal-Ince</surname> <given-names>D</given-names>
</name>
<name>
<surname>&#xd6;z&#xe7;elik</surname> <given-names>U</given-names>
</name>
<name>
<surname>Mutlu</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Developmental Functioning Outcomes in Infants With Cystic Fibrosis: A 24- to 36-Month Follow-Up Study</article-title>. <source>Phys Ther</source> (<year>2022</year>) <volume>102</volume> doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ptj/pzac037</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podg&#xf3;rski</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sumi&#x144;ska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rachel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fichna</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fichna</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mazur</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2022</year>) <volume>13</volume> doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.1074209</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>